Acute Ischemic Stroke and Transient Ischemic Attack in ST-Segment Elevation Myocardial Infarction Patients Who

Tsukasa Murakami1, Kenichi Sakakura1, Hiroyuki Jinnouchi1

  • 1Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City 330-8503, Japan.

Insights

Acute ischemic stroke (AIS) and transient ischemic attack (TIA) are critical complications after ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Cardiogenic shock, new-onset atrial fibrillation, and specific procedural factors increase AIS/TIA risk.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Cardiology

Background:

  • Acute ischemic stroke (AIS) and transient ischemic attack (TIA) are rare but serious complications following ST-elevation myocardial infarction (STEMI).
  • Invasive procedures like primary percutaneous coronary intervention (PCI) for STEMI may increase the risk of AIS/TIA.
  • Identifying factors associated with in-hospital AIS/TIA in STEMI patients undergoing primary PCI is crucial for risk mitigation.

Purpose of the Study:

  • To investigate the factors associated with in-hospital AIS/TIA in patients with STEMI who underwent primary PCI.
  • To compare clinical outcomes between STEMI patients who developed AIS/TIA and those who did not.

Main Methods:

  • A cohort of 941 STEMI patients undergoing primary PCI was analyzed.
  • Patients were divided into an AIS/TIA group (n=39) and a non-AIS/TIA group (n=902).
  • Multivariate logistic regression analysis was employed to identify associated factors.

Main Results:

  • The incidence of in-hospital death was significantly higher in the AIS/TIA group (46.2%) compared to the non-AIS/TIA group (6.3%).
  • Multivariate analysis identified cardiogenic shock, new-onset atrial fibrillation (AF), trans-femoral approach, use of ≥4 catheters, and BARC type 3 or 5 bleeding as significantly associated with AIS/TIA.
  • These factors showed odds ratios ranging from 2.280 to 3.715.

Conclusions:

  • New-onset AIS/TIA in STEMI patients undergoing primary PCI is significantly associated with cardiogenic shock, new-onset AF, trans-femoral approach, extensive catheter use, and major bleeding.
  • Recognizing these modifiable and unmodifiable risk factors is essential for managing STEMI patients and preventing AIS/TIA.
  • These findings highlight the need for careful procedural planning and patient monitoring during primary PCI for STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
47
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
21